ArticleScience advances2022
Development of iPSC-based clinical trial selection platform for patients with ultrarare diseases.
Glen Lester Sequiera et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it